» Authors » Tyler P Robin

Tyler P Robin

Explore the profile of Tyler P Robin including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 45
Citations 753
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Eule C, Candelario N, Nath S, Robin T
Adv Radiat Oncol . 2024 Dec; 9(12):101655. PMID: 39620140
Purpose: Patients with metastatic castrate-resistant prostate cancer (CRPC) with progressive disease generally require a change or escalation in systemic therapy. For patients with limited (1-3) sites of progressive disease (oligoprogression),...
2.
Eule C, Warren A, Kuna E, Robin T, Gershman B, Kim S, et al.
Prostate Cancer Prostatic Dis . 2024 Nov; PMID: 39572637
Background: Small cell prostate cancer (SCPC) is a rare, aggressive disease with limited clinical data to guide treatment. In this retrospective study, we evaluated clinical, treatment, and outcomes data for...
3.
Eule C, Kuna E, Robin T, Gershman B, Flaig T, Kim S
Urol Oncol . 2024 Aug; 42(12):447.e17-447.e24. PMID: 39191549
Background: In metastatic hormone-sensitive prostate cancer (mHSPC), androgen deprivation therapy and standard of care treatment intensification with docetaxel and/or an androgen receptor signaling inhibitor (ARSI) are associated with improved survival...
4.
Shiao J, Gao D, Mueller A, Holt D, Moskalenko M, Zaccone J, et al.
Adv Radiat Oncol . 2024 Feb; 9(2):101372. PMID: 38405320
Purpose: Limited structured educational programs are available for the continued professional development of radiation oncology nurses. In this study, we evaluated a pilot curriculum focusing on clinical workflow and toxicity...
5.
Mak K, Scannell Bryan M, Dignam J, Shipley W, Lin Y, Peters C, et al.
Eur Urol Focus . 2024 Feb; 10(2):271-278. PMID: 38307806
Background: Androgen deprivation therapy (ADT) has been associated with coronary heart disease and myocardial infarction (MI) in prostate cancer patients, but controversy persists regarding its effects on cardiovascular mortality (CVM)....
6.
Santoso A, Vinogradskiy Y, Robin T, Goodman K, Schefter T, Miften M, et al.
Adv Radiat Oncol . 2024 Feb; 9(3):101409. PMID: 38298328
Purpose: Positional errors resulting from motion are a principal challenge across all disease sites in radiation therapy. This is particularly pertinent when treating lesions in the liver with stereotactic body...
7.
Grover S, Lichter K, Likhacheva A, Jang J, Ning M, Robin T, et al.
Brachytherapy . 2023 Sep; 22(6):716-727. PMID: 37704540
Purpose: The global cervical cancer burden is disproportionately high in low- and middle-income countries (LMICs), and outcomes can be governed by the accessibility of appropriate screening and treatment. High-dose-rate (HDR)...
8.
Moskalenko M, Jones B, Mueller A, Lewis S, Shiao J, Zakem S, et al.
Curr Oncol . 2023 May; 30(5):5054-5061. PMID: 37232840
Fiducial markers are utilized for image guided radiotherapy (IGRT) alignment during the delivery of liver stereotactic body radiosurgery (SBRT). There are limited data demonstrating the impact of matching fiducials on...
9.
Rusthoven C, Staley A, Gao D, Yomo S, Bernhardt D, Wandrey N, et al.
J Natl Cancer Inst . 2023 May; 115(8):926-936. PMID: 37142267
Introduction: Historical reservations regarding stereotactic radiosurgery (SRS) for small-cell lung cancer (SCLC) brain metastases include concerns for short-interval and diffuse central nervous system (CNS) progression, poor prognoses, and increased neurological...
10.
Fakhoury K, Schubert L, Coyne M, Aldridge W, Zeiler S, Stuhr K, et al.
Cureus . 2023 Feb; 14(12):e33100. PMID: 36721584
The purpose of this report is to present the implementation of a process for after-hours radiation treatment (RT) utilizing remote treatment planning based on optimized diagnostic computed tomography (CT) scans...